India has allowed its pharmaceutical companies to produce generic drugs at the national level, and this has not changed even after joining the WTO.
When Kechuang Bio's endorphins were first introduced, Indian pharmaceutical companies attempted to imitate them.
However, according to Zheng Li's paper on endorphins published in Nature, the production process is very costly and not worthwhile at all.
India has been trying to develop a large-scale industrial production method for endorphins, based on the laboratory preparation method.
Before they could even figure it out, Kechuang Biotech started collaborating with pharmaceutical companies worldwide. They offered to pay patent licensing fees in exchange for sharing the preparation method and allowing companies to use their methods to manufacture endorphins.
In fact, Indian pharmaceutical companies have deep-rooted interests with European and American pharmaceutical companies. Some experiments that are inconvenient to conduct are carried out in India. The specific reasons are quite simple.
Therefore, after the patents of Kechuang Biotechnology were made public, the Indians obtained the industrial production method and began to prepare endorphins on a large scale.
Their costs are similar to those of Kechuang Bio, and 50 percent lower than other pharmaceutical companies that have to pay patent licensing fees.
Endorphins manufactured in India are very popular in underdeveloped areas, mainly because they are cheap.
There's nothing that Kechuang Bio can do about them.
So much so that when Kechuang Bio later reflected on its internal situation, it often brought up this case. When deciding on the patent licensing, no one expected the Indian guy to be involved.
Although Cheng Gang is a veteran in the biopharmaceutical industry, there are very few innovative drugs in China, and almost none that can be copied by India.
During the subsequent internal review, it was unanimously agreed that, given the availability of sufficient cash, the company should not have rushed to license its technology patents.
The vice president in charge of innovative drugs at Kechuang Biotechnology has consistently emphasized the importance of considering reverse engineering resistance during drug development to prevent the drugs from being easily copied by Indian companies.
Returning to the topic of biotechnology, the significance of super batteries lies primarily in their application.
New energy vehicles will create a new wave globally, putting even more pressure on gasoline-powered vehicles.
However, the source of energy has not changed in essence. Super batteries still need to be charged, and charging still requires energy from thermal power, hydropower, nuclear power, and other sources.
Unlike crystalline silicon photovoltaic cells, which double the conversion efficiency, photovoltaic power generation completely replaces thermal power generation, fundamentally solving the energy problem.
Of course, even if the conversion efficiency of photovoltaic cells doubles, the cost of large-scale industrial production must be considered. If the cost is too high, it will be difficult to replace thermal power generation.
For Earth, controlled nuclear fusion is theoretically the best path.
Twenty years ago, a popular science magazine said that controlled nuclear fusion was still fifty years away from us, and it seems that it is still fifty years away now.
In recent years, the progress seems to have accelerated. The Chinese sun broke the world record, burning at 120 million degrees Celsius for 101 seconds.
However, the estimate that controlled nuclear fusion will take fifty years to go from the laboratory to grid-connected power generation is still optimistic.
The A-share market closed after the meeting.
Kechuang Bio's weekly board meetings are held on Fridays, if there are any agenda items; otherwise, they are postponed.
Cheng Gang knew he only had two days. The news of the successful development of the Kechuang Biotechnology super battery would spread quickly. He knew his subordinates well.
Even executives unfamiliar with capital operations will have gained knowledge about capital operations through various channels after experiencing the listing of Kechuang Bio and so on.
Humans are driven by self-interest, and it's inevitable that some senior executives will collude with the organization to profit from the situation. Cheng Gang, judging others by his own experience, knew this was bound to happen.
Fortunately, he has two days to do it.
Furthermore, Zheng Li's super samples have not yet arrived, so the market response will not be too strong.
Kechuang Bio, a company that works on brain-computer interfaces and biomedicine, suddenly announced that it has developed a super battery.
The credibility is questionable.
If CATL were to advertise like this, the market response would be overwhelming, enough to trigger a surge in price increases across other lithium battery companies.
Kechuang Bio has a high reputation and significant influence, but not in the lithium battery field. Kechuang Bio has no prior achievements in the lithium battery sector to prove itself.
Even Cheng Gang himself doubted whether the super battery's actual effects were truly as Zheng Li claimed.
However, even if he finds an organization to cooperate with in advance, the results are not guaranteed to be as expected.
Even a small technological breakthrough can be exploited to fleece investors.
Of course, if lithium metal cathodes are really as Zheng Li says, then it's not about exploiting retail investors; it's about investing in value ahead of time.
Chinese new energy vehicle companies will surely seize this opportunity to expand their market share, and may even occupy a large portion of overseas markets.
Among the emerging Chinese electric vehicle manufacturers, NIO has been in the Norwegian market for over a year, and even released a Norway strategy in 2021.
Two months later, in July, NIO sold only two cars in Norway, while XPeng, without much fanfare, sold 31 cars in Norway.
Ford was the best-selling Ford that month, selling 898 units.
With the support of super batteries, domestically produced new energy vehicles have at least gained their own core advantages in overseas markets.
The only problem here is that if Kechuang Bio's super battery technology is only open to Chinese automakers, it will definitely not escape the Europa League's anti-monopoly investigation.
Cheng Gang did not raise this question at the meeting; he planned to have a private talk with Zheng Li about it.
In his view, if Kechuang Bio wants to become a multinational giant, it cannot only consider the Chinese market.
Regarding brain-computer interface technology, they'll just have to pay the fines, since the phone manufacturers will foot the bill anyway. The Europa Union can't possibly wipe out all their profits; the most likely scenario is that they'll confiscate a percentage of their patent licensing fees in the European market.
Cheng Gang thought it was better than not making any money at all, and more importantly, expanding the influence of Kechuang Biotechnology in the European region.
This is to facilitate the future release of brain-computer interface VR in Europe. Europe and America are the most important source of revenue for indie games.
For brain-computer interface VR to create a completely new ecosystem, the Europa Alliance is an important market.
Cheng Gang felt that Zheng Li was young and impetuous, and he planned to persuade him from a business perspective.
While internal disagreements arose regarding the development path within the company, Japan and England finally reached an agreement.
England paid certain political concessions to obtain the right to use Magic Brain, while the ownership of Magic Coin is in the hands of Japan, and Japan will be involved in the use of Magic Brain throughout the process.
They need to find out who used the Demon Brain.
England didn't hesitate much; they chose to give the first Magic Brain to Wiles, who proved Fermat's Last Theorem.
As for why it has been exclusively used by scientists and not by politicians, that's why it remains so popular.
It's a consensus, though without evidence, that Merlin left a backdoor in the Demon's Mind because of a backdoor.
What if politicians are injected with the Demon Brain and then controlled by Merlin, or even have their memories read remotely?
Could Merlin even go a step further, turning memories into images and then broadcasting them widely?
There are too many uncontrollable risks.
Continue read on readnovelmtl.com
